Azithromycin and high-dose vitamin D for treatment and prevention of asthma-like episodes in hospitalised preschool children: study protocol for a combined double-blind randomised controlled trial

Introduction Previous randomised controlled trials (RCTs) suggest antibiotics for treating episodes of asthma-like symptoms in preschool children. Further, high-dose vitamin D supplementation has been shown to reduce the rate of asthma exacerbations among adults with asthma, while RCTs in preschool children are lacking. The aims of this combined RCT are to evaluate treatment effect of azithromycin on episode duration and the preventive effect of high-dose vitamin D supplementation on subsequent episodes of asthma-like symptoms among hospitalised preschoolers. Methods and analysis Eligible participants, 1–5 years old children with a history of recurrent asthma-like symptoms hospitalised due to an acute episode, will be randomly allocated 1:1 to azithromycin (10 mg/kg/day) or placebo for 3 days (n=250). Further, independent of the azithromycin intervention participants will be randomly allocated 1:1 to high-dose vitamin D (2000 IU/day+ standard dose 400 IU/day) or standard dose (400 IU/day) for 1 year (n=320). Participants are monitored with electronic diaries for asthma-like symptoms, asthma medication, adverse events and sick-leave. The primary outcome for the azithromycin intervention is duration of asthma-like symptoms after treatment. Secondary outcomes include duration of hospitalisation and antiasthmatic treatment. The primary outcome for the vitamin D intervention is the number of exacerbations during the treatment period. Secondary outcomes include time to first exacerbation, symptom burden, asthma medication and safety. Ethics and dissemination The RCTs are approved by the Danish local ethical committee and conducted in accordance with the guiding principles of the Declaration of Helsinki. The Danish Medicines Agency has approved the azithromycin RCT, which is monitored by the local Unit for Good Clinical Practice. The vitamin D RCT has been reviewed and is not considered a medical intervention. Results will be published in peer-reviewed journals and presented at international conferences. Trial registration numbers NCT05028153, NCT05043116.

[1]  Shiraz A. Shah,et al.  The infant gut resistome associates with E. coli, environmental exposures, gut microbiome maturity, and asthma-associated bacterial composition. , 2021, Cell host & microbe.

[2]  Shiraz A. Shah,et al.  The Airway Microbiota Modulates Effect of Azithromycin Treatment for Episodes of Recurrent Asthma-like Symptoms in Preschool Children: A Randomized Clinical Trial. , 2021, American journal of respiratory and critical care medicine.

[3]  K. Bønnelykke,et al.  Airway immune mediator levels during asthma‐like symptoms in young children and their possible role in response to azithromycin , 2020, Allergy.

[4]  S. Sørensen,et al.  Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial , 2018, EBioMedicine.

[5]  B. Davidson,et al.  Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations , 2017, Chest.

[6]  David A. Jolliffe,et al.  Vitamin D for the management of asthma. , 2023, The Cochrane database of systematic reviews.

[7]  David W Johnson,et al.  Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: A placebo-controlled randomized trial , 2017, PloS one.

[8]  A. Laupacis,et al.  Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children , 2017, JAMA.

[9]  David A. Jolliffe,et al.  Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data , 2017, British Medical Journal.

[10]  M. Guertin,et al.  Factors associated with failure of emergency department management in children with acute moderate or severe asthma: a prospective, multicentre, cohort study. , 2016, The Lancet. Respiratory medicine.

[11]  John H. White,et al.  Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial , 2016, Trials.

[12]  C. Pipper,et al.  Azithromycin for episodes with asthma-like symptoms in young children aged 1–3 years: a randomised, double-blind, placebo-controlled trial , 2015, The Lancet Respiratory Medicine.

[13]  M. Cabana,et al.  Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. , 2015, JAMA.

[14]  Helen K. Reddel,et al.  A summary of the new GINA strategy: a roadmap to asthma control , 2015, European Respiratory Journal.

[15]  K. Bønnelykke,et al.  Duration of wheezy episodes in early childhood is independent of the microbial trigger , 2015, Journal of Allergy and Clinical Immunology.

[16]  M. Chatfield,et al.  Three-Weekly Doses of Azithromycin for Indigenous Infants Hospitalized with Bronchiolitis: A Multicentre, Randomized, Placebo-Controlled Trial , 2015, Front. Pediatr..

[17]  K. Bønnelykke,et al.  Neonates with reduced neonatal lung function have systemic low-grade inflammation , 2015, Journal of Allergy and Clinical Immunology.

[18]  H. Bisgaard,et al.  Increased risk of pneumonia and bronchiolitis after bacterial colonization of the airways as neonates. , 2013, American journal of respiratory and critical care medicine.

[19]  D. Postma,et al.  VEGFA variants are associated with pre‐school lung function, but not neonatal lung function , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  M. Chatfield,et al.  A Single Dose of Azithromycin Does Not Improve Clinical Outcomes of Children Hospitalised with Bronchiolitis: A Randomised, Placebo-Controlled Trial , 2013, PloS one.

[21]  M. Holick,et al.  Influence of Vitamin D Status and Vitamin D3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial , 2013, PloS one.

[22]  K. Bønnelykke,et al.  Neonatal cytokine profile in the airway mucosal lining fluid is skewed by maternal atopy. , 2012, American journal of respiratory and critical care medicine.

[23]  K. Bønnelykke,et al.  "To wheeze or not to wheeze": That is not the question. , 2012, The Journal of allergy and clinical immunology.

[24]  H. Bisgaard,et al.  "To wheeze or not to wheeze": that is not the question--the sequel. , 2012, The Journal of allergy and clinical immunology.

[25]  Efsa Panel on Dietetic Products.  Scientific Opinion on the Tolerable Upper Intake Level of vitamin D , 2012 .

[26]  P. Sly,et al.  Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment , 2012, Nature Medicine.

[27]  A. Fitzpatrick,et al.  Vitamin D and asthma , 2012, Dermato-endocrinology.

[28]  M. Schatz,et al.  Daily or intermittent budesonide in preschool children with recurrent wheezing. , 2011, The New England journal of medicine.

[29]  Q. Hamid,et al.  Vitamin D Deficiency as a Strong Predictor of Asthma in Children , 2011, International Archives of Allergy and Immunology.

[30]  C. Pipper,et al.  Endotyping early childhood asthma by quantitative symptom assessment. , 2011, The Journal of allergy and clinical immunology.

[31]  K. Bønnelykke,et al.  Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study , 2010, BMJ : British Medical Journal.

[32]  D. Voaklander,et al.  Asthma presentations by children to emergency departments in a Canadian province: A population‐based study , 2010, Pediatric pulmonology.

[33]  S. Teach,et al.  High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. , 2010, The Journal of pediatrics.

[34]  C. Sorkness,et al.  Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. , 2008, The Journal of allergy and clinical immunology.

[35]  David Proud,et al.  Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. , 2008, American journal of respiratory and critical care medicine.

[36]  Hans Bisgaard,et al.  Childhood asthma after bacterial colonization of the airway in neonates. , 2007, The New England journal of medicine.

[37]  Hans Bisgaard,et al.  Prevalence of asthma‐like symptoms in young children , 2007, Pediatric pulmonology.

[38]  W. Teague,et al.  Prevalence of viral respiratory tract infections in children with asthma , 2006, Journal of Allergy and Clinical Immunology.

[39]  H. Bisgaard,et al.  Intermittent inhaled corticosteroids in infants with episodic wheezing. , 2006, The New England journal of medicine.

[40]  T. To,et al.  The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. , 2006, Chest.

[41]  H. Bisgaard,et al.  Variations in pediatric asthma hospitalization rates and costs between and within Nordic countries. , 2004, Chest.